Construction and application of a high-fidelity CRISPR/AsCpf1 mutant
A mutant and gene editing technology, applied in the field of high-fidelity CRISPR/AsCpf1 mutant construction, can solve the problem of few high-fidelity versions, and achieve good fidelity, good target cutting activity, and good specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Embodiment 1 Recombinant expression plasmid construction
[0034] The sequence of pU6-CAG-AsCpf1-mCherry is shown in SEQ ID NO:5.
[0035]With wild-type pU6-CAG-AsCpf1-mCherry ( figure 1 ) as a carrier (its nucleotide sequence is shown in SEQ ID NO: 5), using Gibson Assembly principle technology, design corresponding mutation primers, perform PCR, and finally connect to obtain pU6-CAG-AsCpf1-KA-mCherry ( figure 2 ). details as follows:
[0036] First, the pU6-CAG-AsCpf1-mCherry vector was digested with PmI I and BamHI to obtain the backbone vector. Using pU6-CAG-AsCpf1-mCherry as a template, PCR amplified fragments containing mutated bases respectively. The sequences of PCR primers are as follows:
[0037] AsCpf1-Pml I-F: 5'-ACCAGCGACAAGTTCTTTTTCCACGTGCCTATCA-3'; (SEQ ID NO: 6)
[0038] AsCpf1-KA-R: 5'-CACAGACCAGGCCTGAGCGGCCGCCACCTTCTCTTCTCCCTGTG-3'; (SEQ ID NO: 7)
[0039] AsCpf1-KA-F: 5'-GAAGGAGAAGGTGGCGGCCGCTCAGGCCTGGTCTGTGGTGGGC-3'; (SEQ ID NO: 8)
[0040] A...
Embodiment 2
[0045] Example 2 specificity verification
[0046] In order to verify that the fidelity of the obtained mutant AsCpf1-KA (ie, the AsCpf1 mutant) is better than that of the wild-type AsCpf1, the following experiments were designed for specificity verification:
[0047] (1) According to literature reports (BP Kleinstiver, et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells, Nartue.2016), wild-type AsCpf1 can cut some gRNAs even if they are not completely matched, especially 1 , 2, 8, 9, 19, 20, 21, 22, 23 and other positions. That is to say, the wild-type AsCpf1 can tolerate some base mismatches of gRNA, that is, the specificity is average. Therefore, we designed a gRNA targeting the site of DNMT1-site3 for verification, including a fully matched on-target site (ON), and mismatch 1 (mm1), mismatch 8 (mm8), and mismatch 9 (mm9), mismatch 19 (mm19), mismatch 20 (mm20) and other gRNAs, the specific sequence is as follows:
[0048] AsCpf1-gRNA-DNMT1-3-ON:...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


